• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

世界为应对未来大流行和国际关注的突发公共卫生事件做准备:多种多边获取与惠益分享机制的比较以及世卫组织一项针对具有大流行潜力病原体的新机制对日本获取与惠益分享政策的影响

The world preparing for future pandemics and public health emergencies of international concern: Comparison of various multilateral access and benefit-sharing mechanisms and the impact of a new WHO mechanism for pathogens with pandemic potential on Japanese access and benefit-sharing policy.

作者信息

Nakamura Saki, Matsuo Makiko

机构信息

Institute for Future Initiatives, The University of Tokyo, Tokyo, Japan.

Graduate School of Public Policy, The University of Tokyo, Tokyo, Japan.

出版信息

Glob Health Med. 2025 Apr 30;7(2):127-140. doi: 10.35772/ghm.2025.01000.

DOI:10.35772/ghm.2025.01000
PMID:40321444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12047031/
Abstract

Currently, there is a member-state-led discussion in the Intergovernmental Negotiating Body of the World Health Organization (WHO) to draft and negotiate a convention, agreement, or other international instrument under the Constitution of the WHO to strengthen global pandemic prevention, preparedness, and response (WHO CA+). An access and benefit-sharing (ABS) mechanism for pathogens is likely to be a key element of this instrument, as it may provide legal certainty for rapid pathogen sharing and global access to medical countermeasures against future pandemics and in some cases public health emergencies of international concern, which are expected to be provided to countries in need. A multilateral ABS mechanism may resolve issues arising from the bilateral nature of the current ABS mechanism established under the Nagoya Protocol (which requires recipients to decipher the complex web of ABS legislation, thereby preventing rapid access to pathogens), and may also improve uneven global access to medical countermeasures during pandemics. This study analyzes the ongoing WHO discussion on ABS mechanisms while reviewing other examples of such mechanisms, including those outside the health sector. Additionally, there is a growing global interest in mapping national policies on ABS, as discussions on international policies are ongoing in multiple fora. This study furthermore introduces Japan's ABS policy, which is not widely known, and explores how the new WHO mechanism could affect Japan, namely highlighting the importance and the challenges of participating in such a system for industry and academia in the context of a developed country.

摘要

目前,世界卫生组织(WHO)政府间谈判机构正在进行一场由成员国主导的讨论,旨在根据WHO章程起草并协商一项公约、协定或其他国际文书,以加强全球大流行预防、防范和应对(WHO CA+)。病原体的获取和惠益分享(ABS)机制很可能是该文书的关键要素,因为它可为病原体的快速共享以及全球获取针对未来大流行以及某些情况下国际关注的突发公共卫生事件的医疗应对措施提供法律确定性,这些应对措施预计将提供给有需要的国家。多边ABS机制可能会解决因根据《名古屋议定书》设立的现行ABS机制的双边性质而产生的问题(该机制要求接受方解读复杂的ABS立法网络,从而阻碍了对病原体的快速获取),还可能改善大流行期间全球获取医疗应对措施不均衡的状况。本研究分析了WHO目前关于ABS机制的讨论,同时回顾了此类机制的其他实例,包括卫生部门以外的实例。此外, 随着多个论坛正在进行关于国际政策的讨论,全球对梳理各国ABS政策的兴趣也与日俱增。本研究还介绍了鲜为人知的日本ABS政策,并探讨新的WHO机制可能如何影响日本,即在发达国家背景下,突出该系统对产业界和学术界的重要性以及参与其中所面临的挑战。

相似文献

1
The world preparing for future pandemics and public health emergencies of international concern: Comparison of various multilateral access and benefit-sharing mechanisms and the impact of a new WHO mechanism for pathogens with pandemic potential on Japanese access and benefit-sharing policy.世界为应对未来大流行和国际关注的突发公共卫生事件做准备:多种多边获取与惠益分享机制的比较以及世卫组织一项针对具有大流行潜力病原体的新机制对日本获取与惠益分享政策的影响
Glob Health Med. 2025 Apr 30;7(2):127-140. doi: 10.35772/ghm.2025.01000.
2
Access by Design, Benefits if Convenient: A Closer Look at the Pandemic Influenza Preparedness Framework's Standard Material Transfer Agreements.按需获取,便利获益:更深入了解大流行性流感防范框架的标准物资转让协议。
Milbank Q. 2019 Mar;97(1):91-112. doi: 10.1111/1468-0009.12364. Epub 2019 Jan 13.
3
Global patterns in access and benefit-sharing: a comprehensive review of national policies.获取与惠益分享的全球模式:国家政策的全面审查
BMJ Public Health. 2025 Mar 4;3(1):e001800. doi: 10.1136/bmjph-2024-001800. eCollection 2025 Jan.
4
Equity in the Pandemic Treaty: Access and Benefit-Sharing as a Policy Device or a Rhetorical Device?大流行条约中的公平性:获取与惠益分享是政策工具还是修辞工具?
J Law Med Ethics. 2023;51(1):217-220. doi: 10.1017/jme.2023.59. Epub 2023 May 25.
5
Access and Benefit Sharing Under the Nagoya Protocol-? Six Latin American Case Studies Assessing Opportunities and Risk.《名古屋议定书》下的获取与惠益分享——六个拉丁美洲案例研究:评估机遇与风险
Front Pharmacol. 2020 Jun 8;11:765. doi: 10.3389/fphar.2020.00765. eCollection 2020.
6
Pandemic treaty as an instrument to strengthen global health security: Global health diplomacy at its crux.作为加强全球卫生安全手段的大流行条约:处于关键节点的全球卫生外交。
Health Promot Perspect. 2024 Mar 14;14(1):9-18. doi: 10.34172/hpp.42744. eCollection 2024 Mar.
7
Operationalizing "One Health" as "One Digital Health" Through a Global Framework That Emphasizes Fair and Equitable Sharing of Benefits From the Use of Artificial Intelligence and Related Digital Technologies.通过一个强调公平和公正分享人工智能和相关数字技术应用所带来的利益的全球框架,将“One Health”付诸实践为“One Digital Health”。
Front Public Health. 2022 May 3;10:768977. doi: 10.3389/fpubh.2022.768977. eCollection 2022.
8
COVID-19 Tests the Limits of Biodiversity Laws in a Health Crisis: Rethinking "Country of Origin" for Virus Access and Benefit-sharing.新冠疫情大流行对卫生危机中的生物多样性法律提出了挑战:重新思考病毒获取和惠益分享的“起源国”。
J Law Med. 2021 Mar;28(3):684-706.
9
Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology.《名古屋遗传资源获取与惠益分享议定书》解读及其对微生物学的影响
Microbiology (Reading). 2017 Mar;163(3):289-296. doi: 10.1099/mic.0.000425. Epub 2017 Mar 29.
10
Balanced Options for Access and Benefit-Sharing: Stakeholder Insights on Provider Country Legislation.获取与惠益分享的平衡选项:利益相关者对提供国立法的见解
Front Plant Sci. 2019 Oct 1;10:1175. doi: 10.3389/fpls.2019.01175. eCollection 2019.

本文引用的文献

1
Global patterns in access and benefit-sharing: a comprehensive review of national policies.获取与惠益分享的全球模式:国家政策的全面审查
BMJ Public Health. 2025 Mar 4;3(1):e001800. doi: 10.1136/bmjph-2024-001800. eCollection 2025 Jan.
2
Recombinant Protein Vaccines against Human Betacoronaviruses: Strategies, Approaches and Progress.针对人类贝塔冠状病毒的重组蛋白疫苗:策略、方法和进展。
Int J Mol Sci. 2023 Jan 15;24(2):1701. doi: 10.3390/ijms24021701.
3
Advances in COVID-19 mRNA vaccine development.新冠病毒信使核糖核酸疫苗研发进展
Signal Transduct Target Ther. 2022 Mar 23;7(1):94. doi: 10.1038/s41392-022-00950-y.
4
Nagoya Protocol and Infectious Diseases: Hindrance or Opportunity?《名古屋议定书》与传染病:阻碍还是机遇?
Front Public Health. 2020 Jun 16;8:238. doi: 10.3389/fpubh.2020.00238. eCollection 2020.
5
Policy opportunities to enhance sharing for pandemic research.加强大流行研究共享的政策机遇。
Science. 2020 May 15;368(6492):716-718. doi: 10.1126/science.abb9342.
6
When the cure kills-CBD limits biodiversity research.当治疗带来伤害——大麻二酚限制生物多样性研究。
Science. 2018 Jun 29;360(6396):1405-1406. doi: 10.1126/science.aat9844.
7
The global health law trilogy: towards a safer, healthier, and fairer world.全球卫生法三部曲:迈向更安全、更健康、更公平的世界。
Lancet. 2017 Oct 21;390(10105):1918-1926. doi: 10.1016/S0140-6736(17)31261-8. Epub 2017 May 15.
8
Treaty to stop biopiracy threatens to delay flu vaccines.制止生物剽窃的条约可能会延迟流感疫苗的生产。
Nature. 2017 Feb 8;542(7640):148. doi: 10.1038/542148a.
9
Explanation of the Nagoya Protocol on Access and Benefit Sharing and its implication for microbiology.《名古屋遗传资源获取与惠益分享议定书》解读及其对微生物学的影响
Microbiology (Reading). 2017 Mar;163(3):289-296. doi: 10.1099/mic.0.000425. Epub 2017 Mar 29.
10
Developing Global Norms for Sharing Data and Results during Public Health Emergencies.制定公共卫生紧急事件期间数据和结果共享的全球规范。
PLoS Med. 2016 Jan 5;13(1):e1001935. doi: 10.1371/journal.pmed.1001935. eCollection 2016 Jan.